☆ 4.7 Letter

EGFR blockade confers sensitivity to cabozantinib in hepatocellular carcinoma

CELL DISCOVERY (2022)

Get Full Text
Add to Collection

Journal

CELL DISCOVERY
Volume 8, Issue 1, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41421-022-00425-y

Keywords

-

Categories

Cell Biology

Funding

  1. National Natural Science Foundation of China [81920108025, 81874229, 82072633, 82122047]
  2. National Facility for Translational Medicine [TMSK-2020-005, TMSK-2021-129]
  3. Natural Science Foundation of Shanghai [22ZR1480900]
  4. Shanghai Municipal Science and Technology Major Project [20JC141100]
  5. Shanghai Cancer Institute [GCYJ-22-03, ZZ9421-13]
  6. China National Postdoctoral Program for Innovative Talents [BX20211187]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.